Improving Patient Safety by Supporting Older Adults in Managing Sleep Problems.

Recruiting N/A Interventional Study
Benzodiazepines Deprescribing Sleep Problems
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
470 (estimated)
Sponsor
Insel Gruppe AG, University Hospital Bern · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Among older adults (≥65 years), use of sleeping pills, such as benzodiazepines and other sedative-hypnotics, to treat sleep problems is common. While sleeping pills are effective in the first few weeks of use, their effect diminishes significantly after that. Especially older adults are susceptible to significant adverse effects of sleep pills, yet stopping sleeping pills remains challenging. BE-S…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * ≥65 years old * BSH (ATC codes N05BA, N05CF, N05CD, and N03AE01) use on average ≥3 times a week during the last 3 months prior to providing informed consent, as self-reported by the patient or by the informal carer * Taking BSH for sleep problems, as self-reported by the patie…
Contacts

Nicolas Rodondi, MD, MAS

+41 31 632 00 69

nicolas.rodondi@insel.ch

CONTACT

Carole E Aubert, MD, MSc

+41 31 664 24 34

caroleelodie.aubert@insel.ch

CONTACT